TipRanks
China Regenerative Medicine International Limited (HK:8158)
:8158
Hong Kong Market
8158
China Regenerative Medicine International Limited
RESEARCH TOOLSreports
Want to see HK:8158 full AI Analyst Report?

China Regenerative Medicine International Limited (8158) Ratios

0 Followers

China Regenerative Medicine International Limited Ratios

HK:8158's free cash flow for Q2 2026 was HK$0.58. For the 2026 fiscal year, HK:8158's free cash flow was decreased by HK$ and operating cash flow was HK$0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.57 1.14 0.99 1.14 1.57
Quick Ratio
 1.35 1.12 0.99 1.14 1.57
Cash Ratio
 0.03 0.11 0.39 0.02 0.01
Solvency Ratio
 0.52 0.33 0.26 -0.55 0.06
Operating Cash Flow Ratio
 0.26 0.05 0.31 0.04 -0.11
Short-Term Operating Cash Flow Coverage
 1.27 1.13 5.04 0.47 -0.36
Net Current Asset Value
HK$ 8.11MHK$ -28.55MHK$ -52.20MHK$ -5.53MHK$ 77.10M
Leverage Ratios
Debt-to-Assets Ratio
 0.27 0.31 0.40 0.27 0.26
Debt-to-Equity Ratio
 0.67 0.96 2.13 4.26 0.69
Debt-to-Capital Ratio
 0.40 0.49 0.68 0.81 0.41
Long-Term Debt-to-Capital Ratio
 0.24 0.33 0.64 0.65 0.00
Financial Leverage Ratio
 2.52 3.14 5.39 15.76 2.66
Debt Service Coverage Ratio
 2.23 -0.84 6.27 -6.53 0.22
Interest Coverage Ratio
 28.36 13.63 16.28 -111.45 15.74
Debt to Market Cap
 0.32 0.24 0.55 0.22 0.15
Interest Debt Per Share
 0.13 0.17 0.18 0.18 0.26
Net Debt to EBITDA
 1.46 5.22 1.04 -0.49 4.86
Profitability Margins
Gross Profit Margin
56.41%58.17%63.62%27.95%90.58%
EBIT Margin
9.00%-2.21%20.84%-153.58%21.78%
EBITDA Margin
23.24%11.47%32.93%-137.30%34.76%
Operating Profit Margin
42.54%22.75%20.33%-157.03%29.59%
Pretax Profit Margin
16.33%21.08%19.59%-154.99%19.90%
Net Profit Margin
27.83%38.20%19.59%-154.99%10.97%
Continuous Operations Profit Margin
38.51%38.20%19.59%-154.99%10.97%
Net Income Per EBT
170.43%181.22%100.00%100.00%55.10%
EBT Per EBIT
38.39%92.66%96.34%98.70%67.26%
Return on Assets (ROA)
20.84%16.38%13.08%-57.93%1.65%
Return on Equity (ROE)
54.16%51.47%70.45%-913.25%4.38%
Return on Capital Employed (ROCE)
55.07%17.66%23.98%-286.33%10.44%
Return on Invested Capital (ROIC)
47.95%2.93%21.66%-175.62%3.85%
Return on Tangible Assets
20.84%16.38%13.08%-57.93%1.65%
Earnings Yield
31.65%21.54%19.76%-68.37%1.44%
Efficiency Ratios
Receivables Turnover
 20.30 1.24 145.69 0.44 0.17
Payables Turnover
 10.76 10.04 8.58 20.24 73.85
Inventory Turnover
 3.57 14.82 139.67 112.50 13.69
Fixed Asset Turnover
 5.80 3.11 12.97 4.01 1.55
Asset Turnover
 0.75 0.43 0.67 0.37 0.15
Working Capital Turnover Ratio
 3.14 14.05 8.96 1.24 0.41
Cash Conversion Cycle
 86.40 282.45 -37.41 813.19 2.11K
Days of Sales Outstanding
 17.98 294.19 2.51 827.97 2.09K
Days of Inventory Outstanding
 102.35 24.63 2.61 3.24 26.67
Days of Payables Outstanding
 33.93 36.37 42.53 18.03 4.94
Operating Cycle
 120.33 318.82 5.12 831.22 2.12K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.05 0.01 0.06 0.02 -0.06
Free Cash Flow Per Share
 0.05 0.01 0.06 0.02 -0.07
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 0.98 0.97 0.96 1.15
Dividend Paid and CapEx Coverage Ratio
 223.20 58.51 29.19 23.13 -6.81
Capital Expenditure Coverage Ratio
 223.20 58.51 29.19 23.13 -6.81
Operating Cash Flow Coverage Ratio
 0.41 0.08 0.34 0.13 -0.25
Operating Cash Flow to Sales Ratio
 0.15 0.06 0.20 0.09 -0.43
Free Cash Flow Yield
16.49%3.15%19.68%3.85%-6.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 3.16 4.64 5.06 -1.46 69.56
Price-to-Sales (P/S) Ratio
 0.88 1.77 0.99 2.27 7.63
Price-to-Book (P/B) Ratio
 1.66 2.39 3.56 13.36 3.05
Price-to-Free Cash Flow (P/FCF) Ratio
 6.06 31.74 5.08 25.98 -15.65
Price-to-Operating Cash Flow Ratio
 6.04 31.20 4.91 24.85 -17.95
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.08 -0.04 <0.01 -0.76
Enterprise Value Multiple
 5.25 20.68 4.05 -2.14 26.80
Enterprise Value
 130.75M 170.92M 120.81M 204.38M 386.99M
EV to EBITDA
 5.25 20.68 4.05 -2.14 26.80
EV to Sales
 1.22 2.37 1.33 2.94 9.32
EV to Free Cash Flow
 8.41 42.45 6.83 33.70 -19.12
EV to Operating Cash Flow
 8.37 41.73 6.60 32.25 -21.92
Tangible Book Value Per Share
 0.19 0.18 0.08 0.04 0.36
Shareholders’ Equity Per Share
 0.19 0.18 0.08 0.04 0.36
Tax and Other Ratios
Effective Tax Rate
 -0.35 0.81 0.00 0.00 0.45
Revenue Per Share
 0.35 0.24 0.30 0.24 0.15
Net Income Per Share
 0.10 0.09 0.06 -0.38 0.02
Tax Burden
 1.70 1.81 1.00 1.00 0.55
Interest Burden
 1.81 -9.53 0.94 1.01 0.91
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.46 0.59 0.57 0.56 0.53
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.57 0.15 1.03 -0.06 -2.14
Currency in HKD